Search

Chemosensitive dysfunctions are now considered as frequent and early symptoms of coronavirus disease 2019 (COVID-19). In the last few weeks, researchers' greatest efforts have been focusing mainly on the analysis of olfactory disorders, neglecting taste dysfunctions. According to our psychophysical evaluations, it can be inferred that the pathogenesis of taste disorders in COVID-19 patients is largely smell-independent. Moreover, isolated gustatory disorders are highly specific of SARS-CoV-2 infection. For these reasons, it is essential that gustatory dysfunctions, like olfactory disorders, are included in the COVID-19 guidelines. [ABSTRACT FROM AUTHOR]

The authors investigated the occurrence of dysphonia in COVID-19 patients in Egypt and the videolaryngoscopic findings associated with vocal symptoms. Keywords: Dysphonia; COVID-19; SARS-CoV-2; Voice; Infection; Reflux EN Dysphonia COVID-19 SARS-CoV-2 Voice Infection Reflux 3202 3203 2 11/29/22 20221002 NES 221002 Dear Editor We read the article entitled: " I Vocal Disorders in Patients with COVID 19 in Egypt i " by Aziz Azzam et al. [[1]]. [Extracted from the article]

Keywords: Covid-19; Anosmia; Smell disorders; Corticosteroids; Coronavirus; SARS-CoV-2; Therapy EN Covid-19 Anosmia Smell disorders Corticosteroids Coronavirus SARS-CoV-2 Therapy 3102 3103 2 11/29/22 20221002 NES 221002 Dear Editor, We enjoyed reading the article by Borah et al. [[1]], recently published in your journal. However, these recent pathogenic findings have provided the rationale for the use of systemic and local corticosteroids for the treatment of persistent COVID-19 related olfactory disorders [[5]]. [Extracted from the article]